Cargando…
Antidiabetic and Cardioprotective Effects of Pharmacological Inhibition of GRK2 in db/db Mice
Despite the availability of several therapies for the management of blood glucose in diabetic patients, most of the treatments do not show benefits on diabetic cardiomyopathy, while others even favor the progression of the disease. New pharmacological targets are needed that might help the managemen...
Autores principales: | Cipolletta, Ersilia, Gambardella, Jessica, Fiordelisi, Antonella, Del Giudice, Carmine, Di Vaia, Eugenio, Ciccarelli, Michele, Sala, Marina, Campiglia, Pietro, Coscioni, Enrico, Trimarco, Bruno, Sorriento, Daniela, Iaccarino, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470575/ https://www.ncbi.nlm.nih.gov/pubmed/30934608 http://dx.doi.org/10.3390/ijms20061492 |
Ejemplares similares
-
Dual role of GRK5 in cancer development and progression
por: Gambardella, J, et al.
Publicado: (2016) -
Pharmacological inhibition of GRK2 improves cardiac metabolism and function in experimental heart failure
por: Ciccarelli, Michele, et al.
Publicado: (2020) -
“Freeze, Don’t Move”: How to Arrest a Suspect in Heart Failure – A Review on Available GRK2 Inhibitors
por: Sorriento, Daniela, et al.
Publicado: (2016) -
Exploiting GRK2 Inhibition as a Therapeutic Option in Experimental Cancer Treatment: Role of p53-Induced Mitochondrial Apoptosis
por: Gambardella, Jessica, et al.
Publicado: (2020) -
A Novel Small Peptide Inhibitor of NFκB, RH10, Blocks Oxidative Stress-Dependent Phenotypes in Cancer
por: Gambardella, Jessica, et al.
Publicado: (2018)